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Metabolic, Membrane, and Functional Responses of Human
Polymorphonuclear Leukocytes to Platelet-Activating Factor
By Leah M. Ingraham, Thomas D. Coates, John M. Allen, Coleen P. Higgins,
Robert L. Baehner, and Laurence A. Boxer
The phospholipid mediator of anaphylaxis. platelet-activat-
ing factor (PAF) is chemotactic for polymorphonuclear
leukocytes (PMN). We have examined this agent￿s effects
on several other PMN functions. Human PMN were pre-
pared from heparinized venous blood by Ficoll gradient.
Metabolic burst was examined by measurement of #{176}2 use
and 0 2 production in the presence or absence of PAF
(10-109M). Unless cells were treated with cytochala-
sin-B (5 ￿g/ml), no significant respiratory burst was demon-
strated. However. pretreatment with PAF (107M)
enhanced approximately threefold the #{176}2 utilization found
when cells were subsequently stimulated with 107M
FMLP. PAF also stimulated arachidonic acid metabolism in
‘4C-arachidonic acid-labeled PMN. Thin-layer chromatog-
raphy analysis of chloroform-methanol extracts showed
substances that comigrated with authentic 5-hydroxyeico-
satetraenoic acid had a marked increase in radioactivity
following PAF stimulation at 107M. PAF failed to stimulate
M UCH ATTENTION has been directed in the
past several years to the effects of the synthetic
chemotactic peptides on function of polymorphonu-
clear leukocytes (PMN). N-formyl-methionyl-leucyl-
phenylalanine (FMLP), in addition to its chemoattrac-
tant effects, promotes a variety of responses from
PMN including metabolic burst, degranulation, and
aggregation. Recently, the phospholipid mediator of
anaphylaxis, platelet-activating factor (PAF), has
been shown to be chemotactic for PMN.’ This com-
pound is I -0-alkyl-2-acetyl-sn-glyceryl-3-phos-
phorylcholine (AGEPC),23 and it is released from
leukocytes of a variety of species including human,￿7
rabbit,6tand rat.9 The in vivo effects of PAF, of either
physiologic or synthetic origin, are the same2”#{176}” and
include hypotension, neutropenia, and thrombocytope-
nia. On the cellular level, PAF promotes aggregation
of platelets and chemotaxis in neutrophils.’ We wished
to determine if, like FMLP, PAF has other possible
regulatory effects on PMN function. We report the
results of our investigation of PAF influence on PMN
metabolism, membrane and cell surface changes, and
the functional responses of degranulation, aggregation,
and adherence.
Chemicals
MATERIALS AND METHODS
Synthetic PAF, designated i-a-lecithin-$-acetyl--y-O-alkyl, was
obtained from Calbiochem-Behring Corp. (La Jolla, Calif.). The
preparation that was >98% pure was that of Do and Ramachan-
release of granule enzymes. B-glucuronidase. lysozyme, or
myeloperoxidase unless cytochalasin-B were added. PAF
from 10’M to 10’#{176}M affected PMN surface responses.
PMN labeled with the fluorescent dye. chlorotetracycline.
showed decreased fluorescence upon addition of PAF.
suggesting translocation of membrane-bound cations. Fur-
thor. the rate of migration of PMN in an electric field was
decreased following PAF exposure. a change consistent
with reduced cell surface charge. PMN self-aggregation
and adherence to endothelial cells were both influenced by
PAF (10’M-109M). Aggregation was markedly stimu-
lated by the compound. and the percent PMN adhering to
endothelial cell monolayers increased almost twofold in the
presence of 10 8M PAF. Thus. PAF promotes a variety of
PMN responses: enhances respiratory burst, stimulates
arachidonic acid turnover. alters cell membrane cation
content and surface charge. and promotes PMN self-
aggregation as well as adherence to endothelial cells.
drani2 from chicken egg yolk. The alkyl groups are predominantly
hexadecyl and octadecyl species. A stock solution (2.5 x 104M)
was prepared by dissolving I mg in 7.49 ml of methanol:chloroform
(3:1). This solution was stored at -20#{176}C. Shortly before use, a
sample of the stock was withdrawn and dried under nitrogen gas. A
solution of 0.9% NaCI with 0.25% bovine serum albumin (BSA)
(Fraction V, Sigma Chemical Co., St. Louis, Mo.) was added to give
a concentration between 10 ￿ and 105M. Chlorotetracycline HCI
(CTC), cytochrome-C, type VI, bovine serum albumin (BSA),
superoxide dismutase (SOD), FMLP, cytochalasin-B, and enzyme
substrates were obtained from Sigma Chemical Co. (St. Louis,
Mo.). Authentic 5-hydroxyeicosatetraenoic (5-HETE) was supplied
by Dr. M. Siegel of Burroughs Wellcome Co. (Research Triangle
Park, NC.). 4C-arachidonic acid (55.8 ￿.tCi/.tmole) was obtained
from New England Nuclear (Boston Mass.). Shortly before use, the
isotope was dried under N2 gas, and converted to the sodium salt by
addition of 0.1 M sodium carbonate. Powdered medium 199 (with
Earle’s salts, without NaHCO3), L-glutamine, neomycin sulfate
solution, and fungizone (amphotericin B) were purchased from
Gibco Laboratories, Grand Island i3iological Co., Grand Island,
N.Y.
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Cell Preparation
Heparinized venous blood was obtained from normal volunteers in
accordance with the precepts established by the Helsinki Declara-
tion. PMN were separated by Ficoll gradient’3 and freed of contami-
nating erythrocytes by hypotonic lysis. Final suspension of cells
(95%-99% PMN) was in phosphate-buffered saline (PBS) or Kreb’s
Ringer phosphate (KRP). In some instances, 5.5 mM glucose was
added to the suspending medium (PBSG or KRPG).
Oxygen Consumption
The oxygen consumption by PMN was measured by use of an
oxygen electrode (Model 53, Yellow Springs Instrument Co., Yellow
Springs, Ohio) with an expanded scale Varian recorder (Vaian
Associates, Palo Alto, Calif.). A suspension of i0￿ cells in KRPG
was placed in the reaction vessel. After 5 mm of incubation at 37#{176}C,
Na azide (final concentration I mM) and other agents to be tested
were added to give a final volume of 3 ml. Baseline oxygen
consumption was measured for 5 mm and then 100ul stimulant was
added. Oxygen consumption was recorded an additional 5-I 2 mm.
Results of replicate samples were averaged and expressed as nmoles
#{176}2 used/S min/107 cells.
Superoxide Production
Superoxide ion was measured as the superoxide dismutase (SOD)
sensitive reduction of cytochrome-C as described by Babior et al.’4
Each tube had in a final volume of 0.9 ml: 0.75 ml of KRPG
containing 3x106 cells, I 19 ￿M cytochrome-C, and I mM sodium
azide. In some instances, SOD (60 ￿g) and/or cytochalasin-B (5 ￿g)
were added. After 5 mm equilibration at 37#{176}C, the reaction was
initiated by addition of 100 ￿l stimulant. At the end of the reaction
time (I, 2, 5, or 10 mm), the tube was placed in ice and 0.5 ml of
ice-cold l mM N-ethylmaleimide (NEM) was added. The tubes
were centrifuged (400 g, for 5 mm, 4#{176}C) and the supernatant
absorptions were read at 550 nm on a Gilford Spectrophotometer
(Model 250, Gilford Instruments Co., Oberlin, Ohio). The results of
replicate samples were averaged and converted to nanomoles
reduced cytochrome-C by use of the extinction coefficient of
l9.lxlO3M’ cm’.
Arachidonate Conversions
PMN were suspended in PBSG with 1% BSA, fatty acid free
(PBSGB), at a concentration of l0￿ cells/mi. ‘4C-sodium arachidon-
ate (1-2￿Ci/2xI07 cells) was added. The cells were incubated in a
shaking water bath at 37#{176}C for 30 mm. Ten volumes of PBSGB were
added and the cells were pelleted by centrifugation (1 50 g, 7 mm,
20#{176}C). Cells were resuspended in PBSG to give a cell density of 10￿
cell/mI, and additions of stock solutions of calcium chloride and
magnesium sulfate were added to give final concentration of 1.2 mM
of each of the divalent cations. After 5 mm incubation in a shaking
water bath at 37#{176}C, stimulating agent was added and the incubation
continued for 5 additional minutes. Ice-cold citric acid (final concen-
tration I 5 mM) was added to stop the reaction. The acidified
suspension was extracted with chloroform and methanol by a
modified Bligh and Dyer extraction.’5 The chloroform phase was
dried under nitrogen and redissolved in 100 ￿l volume of chloro-
form:methanol (2: 1, v/v). Forty-five-microliter samples of the
extracts were spotted on silica gel G plates (Uniplate, Analtech,
Newark, Del.) for analysis by thin-layer chromatography. The
plates were developed in one of two solvents: ( I )chloroform:metha-
nol:glacial acetic acid:water (90:8:1:0.8, v/v/v/v) or (2)hexane:di-
ethyl ether:glacial acetic acid (50:50:1, v/v/v). R￿ values for phos-
phatidylcholine, PGE2, 5-HETE, and arachidonic acid are, respec-
tively, for solvent I: 0.02, 0.4, 0.57, and 0.76; and for solvent 2: 0.01,
0.03, 0.28, and 0.65. Location of standards was visualized in iodine
vapor, and the lanes for each sample were scraped in 0.5-cm sections.
The radioactivity associated with sections corresponding to authen-
tic 5-HETE was determined in a Packard Model 460D Liquid
scintillation spectrometer (Packard instruments, Downey Grove,
Ill.). Results of replicate samples were averaged and expressed as
dpm/107 cells.
Fluorescence Measurements
All fluorescence measurements were made in a Perkin-Elmer
M PF-44B fluorescent spectrophotometer (Perkin-Elmer Corp.
Instrument Div., Norwalk, Conn.) equipped with a temperature-
controlled cuvette holder and automatic stirrer. CTC (final concen-
tration 10 NM), was added to the cell suspension (3xl06 PMN/ml in
Hepes balanced salt containing 10 mM Hepes, pH 7.35, with 130
mM NaCI, 4.5 mM KCI, and 5.5 mM glucose). CaCl2 (1.0 mM
final concentration) was added just before the CTC. The cell
suspensions were incubated for 30 mm at 37#{176}C during which time
the CTC associated with the cell membrane.’6 Two milliliters of
CTC-labeled cell suspension were placed in cuvette and the baseline
fluorescence determined. Generally, instrument settings were such
that unstimulated samples had a baseline fluorescence of 85-95
arbitrary units. Excitation was at 390 nm and emission at 530 nm.
Slit widths were between 6 and 8 nm. Additions of stimulant were
made and the fluorescence was monitored via a recorder for 2-30
mm poststimulation. Results were expressed as percent decrease in
fluorescence at I mm after addition of stimulant.
Electrophoretic Mobility
PMN (l07/ml KRP) were preincubated at 37#{176}C. The stimulant
was added and the cells were incubated for 10 mm at 37#{176}C in a
shaking water bath. At the end of the incubation period, the cell
suspensions were centrifuged at 400 g for 5 mm. The cell pellets were
washed twice in sorbital buffer (4 parts 5% sorbital, I part 1/15 M
Sorenson’s buffer, pH 7.2), and resuspended in sorbital buffer for
final measurement of electrophoretic mobility.
Electrophoretic mobility measurements were made in a modified
Northrop-Kunitz cell mounted in the vertical plane. Observation of
cell movement was made at 400x with a monocular microscope
mounted horizontally. Measurements were made at room tempera-
ture (approximately 23#{176}).
Velocities expressed are the results of the measurement of at least
I 0 cells/sample. The velocity of each cell after applying an electrical
field was determined by measuring the time required to travel a
50-z-distance. The polarity of the field was then reversed and the
time measured in the opposite direction. The mean time to travel
50 ￿L was determined from the formula:
t = 2a(b - a)
b
where t is the actual migration time, a the migration time in one
direction, and b the total migration time in both directions.
The electrophoretic mobility based on the above corrected time is
expressed as .￿m/sec/volt-cm of electrical field. This is done to
correct the velocity for any possible drift in the fluid buffer. All
measurements were made at the first stationary level.
Release of Enzymes
A quantity of 1-1.5 x l0￿ PMN were incubated in 0.9 ml KRPG
for 5 mm at 37#{176}C. Stimulating agent (100 ￿zl) was added and
incubation continued 2.5, 5, or 10 mm longer. At the end of the
incubation, the contents of the tube were centrifuged (400 g, 5 mm,
4#{176}C) and the cell-free supernatant was removed and held at 0#{176}C
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PMN.23 We evaluated the ability of PAF to exert this
effect by measuring 02 utilization and O￿ production
Oxygen utilization in cells incubated with PAF (iOu-
lO6M) was not significantly different from that of
nonstimulated PMN (e.g., with 106M PAF, 15.9 ±
2.5 nmole 02/5 min/107 cells; without stimulation,
18.1 ± 4.5, p = 0.46). Likewise, little 02 production
occurred unless relatively high concentrations were
used and the cells were pretreated with cytochalasin-B
(5 jzg/ml) (Table 1 ). Thus, PAF alone showed little
effect on the PMN respiratory burst. However, if
PMN were treated with PAF (109-106M) for 5 mm
before addition of FMLP (107M), the cells showed a
significant increase in 02 utilization (Table 2). There-
fore, although PAF alone cannot elicit the respiratory
burst, it does appear to “prime” the cells in their
response to the chemoattractant, FMLP.
The ability of PAF to stimulate oxygenation of
arachidonic acid was also evaluated. Cells were labeled
with ‘4C-arachidonic acid and stimulated with 107M
PAF for 5 mm. Substances that comigrated with
authentic 5-HETE showed a marked increase in
radioactivity compared to controls (without PAF
251 ± 51 dpm/lO7cells;with 1O7MPAF, 579.8 ± 38,
p < 0.001). Therefore, it appears that even brief expo-
sure to PAF promotes production of lipoxygenase
endproducts.
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until assay, which was usually performed within 2 hr. Total enzyme
activities were determined on sonicates of I-mI samples of KRPG
containing i0￿ cells. Beta glucuronidase was determined by the
cleavage of p-nitrophenyl-B-D-glucuronide in acetate buffer at pH
4.6 and results were expressed as nanomoles substrate converted/
min/ I O￿ cells. Lysozyme was performed by use of a kit from
Worthington Biochemical Corp. (Freehold, N.J.), and results were
expressed as microgram egg white lysozyme equivalents/ 10￿ cells.
Myeloperoxidase (MPO) was assayed by the method of Paul et al.’7
and results were expressed as nanomoles substrate converted/
min/ l0￿ cells. Lactic acid dehydrogenase (LDH) was determined by
the method of Bergmeyer and Bernt’8 and expressed as nanomoles
NAD reduced/min/107 cells. Typical totals for each of the enzyme
activities are indicated in the footnotes of Table 5. Results of
replicate samples were averaged and expressed as percent total
enzyme released.
Aggregation
Aggregometry was performed as a modification of methods
described by Craddock et aI.’9￿#{176} A standard platelet aggregometer
(Payton, Model 300B) with dual pen recorder was used. To a
siliconized cuvette containing a Teflon stirbar revolving at 600 rpm,
0.45 ml of a suspension containing l0￿ PMN/ml KRP was added.
After a 2-mm delay to allow warming of cells to 37#{176}C,10 ￿.tl
aggregant was added and the resulting changes in light transmission
recorded as EsT. To provide the necessary amplification for a well
defined aggregation wave, the aggregometer recorder system was
calibrated with fresh PMN suspension diluted to a 33% volume with
KRP. Quantitation of PMN aggregation during the intial 3 mm was
made using a Lietz compensating optical polar planimeter (Model
3651-30) and results expressed in square centimeters. The variabil-
ity and total aggregation by PMN during the 4-mm interval did not
exceed 15% on the same day or on subsequent days.
PMN Adherence
Cultures of human endothelial cells were prepared from human
umbilical veins according to the modification by Czervionke et al.2’
of the method of Jaffe et al.22 Cells were suspended in medium 199,
with Earle’s salts (M-l99): 9.87 g/liter medium 199 powder, 2 mM
L-glutamine, 0.05 g/Iiter neomycin sulfate, 0.0025 g/liter fungizone
(amphotericin-B), and 2.2 g/liter NaHCO3, pH 7.4 (M-l99 with
20% human serum in a ratio of 8 parts M- I 99:2 parts human serum).
The cells were seeded in 35 x 10 mm Petri dishes (Falcon Lab,
Division of Becton, Dickinson & Co., Oxford, Calif.) and incubated
in a 5% CO2 atmosphere at 37#{176}C. After 24 hr. the monolayers were
washed with fresh M-I99 with 20% human serum and then
relayered with 2.5 ml of the same medium. Confluent primary
endothelial monolayers, containing 0.7-O.8x106 cells, were used for
adherence studies 4-7 days after seeding. Cell counts were deter-
mined with a hemocytometer after suspension of the cells with 0.25%
trypsin-O.05% trisodium EDTA in phosphate-buffered saline. PMN
from Ficoll gradient were washed twice in KRP, and then suspended
in autologous human serum at a final concentration of 0.8-2.0 x iO￿
PMN/ml. After removal of the M-i99 from the tissue cultures, the
plates were washed twice with Dulbecco’s phosphate-buffered sa-
line, pH 7.4, and then i ml of PMN suspension was added to
triplicate plates just covering the 35-mm diameter surfaces. The
tissue culture-PMN overlay was incubated at 37#{176}C for 15 mm; the
suspension was then aspirated. Comparison of the PMN counts
before and after incubation permitted calculation of the percentage
of PMN adhering to the monolayers. In experiments evaluating the
effect of PAF on the tissue culture-PMN overlay, PAF was added
directly to the experimental plates at concentrations indicated in
Table 6. A gentle agitation followed to assure adequate mixing.
Statistics
Statistical significance was determined by t test comparing PAF-
treated samples with controls incubated with equivalent aliquots of
0.25% BSA in 0.9% NaCI, the suspending medium for PAF.
RESULTS
Metabolic Responses oJPMN to PAF Stimulation
Table 1 . Effect of PAF on Release of Superoxide Ion
From Human PMN
PAF Concentration
Sup￿oxide Releasef
nmole 02 /5 min/107 PMN
- Cytochalasin-B + Cytochalasin-8
None ND￿ ND
5x 107M 6.1 ±0.3￿ 18.0± 2.4
5 x 10￿M 11.5 ± 4.5 35.2 ± 0.5
Cells were incubated in KRPG as described in Materials and Methods.
Some samples received cytochalasin-B (5 ￿zg/ml). After 5 mm incubation
at 37#{176}C, 100 zl of stimulant was added. Samples receiving no PAF had
100 ￿d of 0.9% NaCI with 0.25% BSA. the solvent for PAF.
tAvera￿es and standard deviations from two experiments performed.
*ND. not detected.
§Although the values with PAF are very low. we stimulated these cells
also with zymosan opsonized with human serum (1.6 mg/mI final
concentration). These zymosan-stimulated samples showed a 5-mm
release of 253 nmole O￿; addition of 5 x iO￿ M PAF to zymosan-
stimulated samples had no significant effect on O￿production at 5 mm.
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PMN Stimulated With FMLP. 107M
Table 3. Percent Decrease in Fluorescence of CTC-Labeled PMN
Stimulated With PAF
C 1 x ￿ PMN in KRPG and 1 mM azide were treated 5 mm at 37#{176}C
with PAF at the indicated dosages and then stimulated with FMLP ( 10
M). Results are for one of two experiments performed. Averages and
standard deviation of three replicates are shown.
C. FMLP
+
4
t
U
0
b.PAF PAF I
ONE MIN
Fig. 1 . Response of CTC-labeled human PMN to FMLP or PAF.
Two-milliliter cell suspensions at 3x10 cells/mI Hepes buffered
salt solution were prelabeled 30 mm with 1OsM CTC in presence
of 1 .2 mM Ca2 ￿ . Fluorescence was monitored and the curves are
tracings of the recordings made at the time of the experiment. The
discontinuities represent the shutter closing at time of stimula-
tion. Stimulants were delivered in 5-ed volume at times indicated
by arrows. (A) Cells received 2.5 x 1O7MFMLP. (B) Cells received
2.5 x 107M PAF. (C) Same sample as shown in Fig. 1A. Thirty
minutes after the initial stimulation by 2.5 x 1O7MFMLP. the cells
fail to respond to the same concentration of FMLP but do respond
to 2.5 x 107M PAF. (D) Same sample as that shown in Fig. lB.
Thirty minutes after the initial stimulation by 2.5 x 10 7M PAF. the
cells fail to respond to the same concentration of PAF but do
respond to 2.5 x lO7MFMLP.
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PAF Concentration nmol 02/5 minI 10’ Cells p Value
None 33.3 ± 2.5 -
l09M 52.1 ± 2.2 0.0015
108M 65.1 ±4.3 0.0012
107M 107.1 ±4.5 0.001
10#{176}M 139.6 ± 16.3 0.001
Membrane and Cell Surface Responses ofPMN to
PAF
Chlorotetracycline HC1 (CTC) has been employed
to monitor translocation of calcium from membrane
locations in mammalian cells.24 Rabbit PMN labeled
with CTC exhibit an immediate loss of fluorescence
upon stimulation with chemotactic agents such as
FMLP or C5a,’6 and this has been interpreted as
indicating a removal of calcium from the PMN mem-
brane. We have employed CTC-labeled human cells in
an effort to compare the effects of PAF and of FMLP
on fluorescence intensity. Exposure of human PMN to
2.5xIO￿7M FMLP causes an immediate fluorescence
loss (Fig. IA), as does exposure to 2.5xlO7M PAF
(Fig. I B). Therefore, it appears that both compounds
have similar effects on membrane-associated cations.
a. FMLP
PAF Concentrat.on Percent Decreaset
2.5 x 10￿” M 0.6 ± 0.07
2.5 x 10’#{176}M 2.9 ± 1.5
2.5 x 10’ M 4.2 ± 1.3
2.5 x 10￿ ￿ M 5.9 ± 0.3
2.5 x i￿-￿ M 6.1 ± 0.9
Two milliliters of cells in Hepes balanced salts (3 x 10’/ml) plus 1.2
mM Ca2￿ were incubated with 10 ￿tM CTC for 30 mm. Baseline
fluorescence was determined, 5 p1 PAF dilution was added, and fluores-
cence monitored.
tRan￿e was selected so that baseline fluorescence (in arbitrary units)
was between 85 and 95. Percent was calculated from decrease in
fluorescence units 1 mm after PAF stimulation. Results are mean and
standard deviation of triplicate determinations.
However, the means by which the effect is triggered is
different for the two compounds. Cells stimulated with
FMLP remain refractory to the chemotactic agent for
several minutes following the initial exposure, but if
the second stimulation is PAF, a typical drop in
fluorescence is seen (Fig. IC). The same is true for
PAF-stimulated cells that cannot be restimulated with
PAF but will respond to FMLP (Fig. I D). The magni-
tude of fluorescence change in CTC-labeled PMN
stimulated with PAF varies with PAF concentration
from lO’#{176}Mto 10 8M(Table3).
We have employed electrophoretic mobility of PMN
for studies of changes in cell surface charge. After
exposure to PAF, PMN have decreased mobility (Ta-
ble 4). This change in mobility is consistent with a
decrease in the net negative charge on the cell surface.
The magnitude of the decrease in mobility is similar to
that found for cells treated with FMLP in the absence
of cytochalasin-B (e.g., unstimulated controls, 2.09 ±
0.027 sm/sec/volt-cm; with lO7M FMLP, 1.98 ±
0.05; with lO￿7M PAF, 1.94 ± 0.1 1).
Functional Responses ofHuman PMN to PAF
PAF is chemotactic for PMN.’ We wished to deter-
mine if PAF also elicited other functional responses
Table 4. Effect of PAF o n Electrophoretic Mobility of Human PMN
PAF
Concentration sm/sec/volt-cm’ p Valuef
None
108M
107M
10￿8M
2.09 ± 0.027
2.01 ±0.031
1.94±0.076￿
1.90±0.043
-
0.04
0.04
0.005
Each value represents mean and standard deviation of 1 0 or more
individual determinations
tone-tailed comparison of sample means of at least 2 experiments.
￿Changes with PAF at 10 ￿ M are similar to those obtained with
FMLP at the same concentration, 1 .98 ± 0.05 ￿sm/sec/volt-cm.
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in 0. 9% NaCI
I I I I 1 1 1 I
TIME (MIN)
Fig. 2. Aggregation of human PMN in response to PAF
(10M). T is in arbitrary units. The aggrogometer is set so that full
scale represents the change in light transmission obtained when
the initial cell suspension is diluted 1:3. See Materials and Methods
for details.
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T able 5. Effect of PAF o n Release of Enzymes From Human PMN
Percent Enzyme Release’
PAFt
Concentration
Lysozyme￿ B-glucuronidase￿ MPOf
- cyto-B + cyto-B - cyto-B + cyto-B - cyto-B + cyto-B
None 3.2 ± 0.1 7.3 ± 3.2 4.4 ± 0.1 5.4 ± 1.3 0.9 ± 0.1 1.4 ± 0.6
1 x i￿-￿ 2.2 ± 1.5 11.8 ± 9.2 4.5 ± 0.4 15.1 ± 11.5 1.3 ± 0.5 5.7 ± 5.2
5 >( 10￿ ￿ 2.7 - 0.8 16.6 ± 2.4 5.3 ± 0.4 1 1.3 ± 4.0 1.4 ± 0.6 7.6 ± 7.1
1 x 106 4.0 ± 1.1 17.8 ± 2.4 6.8 ± 2.3 12.1 ± 2.8 1.8 ± 1.1 8.9 ± 6.1
5x 10 6 0.3 16.6 ± 0.8 6.2 ± 0.2 10.3 ± 0.6 1.7 ± 0.6 5.1 ± 0.5
Averages and standard deviation of results from 2 experiments performed.
tCells were incubated in KRPG at 10￿ cells/mI for 5 mm with and without cytochalasin-B (5 ￿g/ml). PAF was added at the indicated concentrations,
and incubation continued an additional 5 mm. Enzyme assays were performed on cell-free supernatants from the suspensions.
￿Total enzyme values were for lysozyme: 25.2 ± 1 1.2 zg egg white lysozyme equivalent per i0￿ cells; for B-glucuronidase 3.47 ± 0.07 nmole
substrate converted/min/ ￿ cells; for MPO 1.76 ± 0.38 mmole substrate converted/min/107 cells. LDH release was less than 5% for all PAF
concentrations tested with or without cytochalasin-B.
typical ofstimulated PMN: selective release of granule
enzymes, aggregation, and adherence.
PAF treatment alone has little effect on degranula-
tion on PMN (Table 5). With cytochalasin-B (5 sg/
ml), which promotes extracellular release of granule
contents, PAF at 5xlO7M caused release of lysozyme
and B-glucuronidase but not of MPO or LDH. With-
out cytochalasin-B, only lysozyme and B-glucuroni-
dase appeared in the extracellular fluid. Increasing
PAF concentration as high as 5x1O6M had little
additional effect on enzyme release.
PAF promoted aggregation of PMN to one another
(Fig. 2, Table 6). The response increased with increas-
ing concentration of PAF from lO￿￿ to 1O￿6M. A
similar effect of PAF was seen on the ability of PMN
to adhere to cultivated endothelial cells (Table 6).
Concentration of PAF as low as lO9M significantly
increased the number of PMN remaining associated
with the monolayers. An increase of PAF to IO￿8M
enchanced this effect but higher concentration did not
further promote adherence.
DISCUSSION
The synthetic peptide, FMLP, and the phospholipid
mediator of anaphylaxis, PAF, both serve as chemoat-
tractants for PMN. We have shown in our present
study that PAF, like FMLP,25 also influences a variety
of PMN responses. However, its effects are distinct
from those of the peptide in some instances.
PAF itself does not intiate the respiratory burst in
non-cytochalasin-B-treated PMN . Unlike FM LP,
which elicits a brief but measurable consumption of 02
and production of 02’ PAF fails to show significant
effects on PMN respiration. Interestingly, PAF treat-
ment of PMN does promote greater 02 utilization
when cells are subsequently stimulated with FMLP. In
addition, PAF stimulated arachidonic acid meta-
holism, Thus, in the inflammatory milieu, PAF may
heighten the oxidative response of PMN and promote
their mobility through increased production of the
chemoattractant HETE.
PAF, like FMLP, exerts influence on the PMN
membrane. The results with CTC-labeled cells suggest
that divalent cations are dislocated from membrane
locations upon PAF stimulation. Similar studies of
FMLP and C5a effects on CTC-labeled PMN led to
the conclusion that calcium was displaced during the
initial ligand-receptor binding,’6 and more recently,
cytochalasin-D as well as Escherichia co/i were also
found to elicit fluorescence changes.26 In the latter
instance, the intracellular calcium antagonist, 8-(N,N-
diethyl-amino)-octyl-3,4,5-trimethoxybenzoate, pre-
vented the changes in CTC fluorescence, lending sup-
port to the idea that calcium was involved. CTC
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Table 6. PAF Effect a on PMN Self-aggregation and Adherence to Endothelial Cells
PAF
Concentration
Aggegation (cm/4 mm)’ Adherence (% Adh erent CeIls)f
Percent p Value - cyto-B + cyto-B p Value
None 2.2 ± 1.0 - 45.6 ± 4.1 -
10￿9M 9.1 ± 1.8 10.1 ± 1.7 0.0005 54.2 ± 6.6 0.0025
108M 26.9 ± 6.9 28.9 ± 0.8 0.0005 71.0 ± 10.6 0.0005
107M 37.3 ± 11.3 39.3 ± 7.3 0.0005 72.0 ± 10.9 0.0005
10￿6M 61.3 ± 8.6 60.4 ± 2.5 0.0005 71.7 ± 11.3 0.0005
‘0.45 x 10#{176} cells in 0.45 ml KRP were incubated for 2 mm at 37#{176}C. PAF indicated dosage was added in 10 d volume and the aggregation wave
recorded. The area under the curve was determined by planimeter and expressed in square centimeters. Results are means and standard deviation for
replicate samples.
tOne milliliter PMN suspensions (0.8-2.0 x 107/ml autologous human serum) were added to Petri plates containing confluent primary endothelial
cell monolayers. The plates were incubated at 37 #{176} C for 15 mm. The suspending fluid was aspirated and numbers of PMN determined.
fluorescence may be affected by factors other than the
availability ofdivalent cations. A difficulty in interpre-
tation of CTC data is the possibility that the dye might
be complexed with cations and then seek a membrane
location rather than serving as a direct probe of
membrane sites already occupied by cations.27 There-
fore, it is not possible to conclude with certainty that
all fluorescence changes are directly related to loss of
cations specifically bound to the membrane. Whatever
the source of the cations involved, the effects of PAF
appear to be very similar to those of FMLP. However,
the PAF response appears to be mediated via a mecha-
nism distinct from that for FMLP. Repeated stimula-
tion by PAF or by FMLP is not possible but sequential
stimulation by first one and then the other is possible.
Assuming that fluorescence loss in CTC-labeled
PMN is due to calcium being released from membrane
stores, we may postulate that the cations becomes
available for regulatory function. Such an effect may
be instrumental in activating certain cell processes. For
example, Ca ￿ ￿ -mediated activation of a phospholipase
A2 could increase the levels of free arachidonic acid
and thus contribute to the increased arachidonate
metabolism following PAF stimulation.
Our electrophoretic mobility studies show that
PAF-treated PMN do have decreased mobility, a
change that is consistent with decreased net negative
charge at the cell surface. Others employing a similar
system have also found evidence of decrease in net
negative surface charge density of PMN following
treatment with C5a or FMLP.283#{176} Displacement of
calcium, as suggested by the CTC data discussed
above, might contribute to changes in cell surface
charge. Many other events occurring during PMN
stimulation probably also alter the net charge. Cation
flux occurs,3’ phospholipid methylation is altered,32
and positively charged proteins are discharged from
granules.33 The relative contribution of these factors,
or ofothers as yet undescribed, to PMN surface charge
change remains unknown.
A diminished negative charge at cell surface should
theoretically enhance cell/cell interaction, and indeed
we do demonstrate, as have others,34’35 enhanced PMN
autoaggregation. In contrast tGour results and those of
O’Flaherty et al.34 and Shaw et al.,35 O’Donnell et al.36
showed inhibition of FMLP-mediated aggregation
when human PMN were pretreated with PAF. The
latter source of PAF was methanolic extracts of anti-
gen-challenged rabbit basophils. The human PMN
also showed diminished aggregation responses to
A23187 and zymosan-activated serum after treatment
with this PAF. The sources, and possibly also the
relative purities, of the PAF preparations for each of
these studies were different,34 36 and these differences
may account for the apparently conflicting effects of
PAF on PMN aggregation. Different tissues within a
single species may give rise to PAF-like substances
that are not identical in their effects on platelet release
of serotonin.37
Consistent with our results of enhanced PMN
autoaggregation following PAF treatment is our find-
ing that adherence of the phagocytes to endothelial
cells is increased in the presence of PAF. One of the
characteristics of in vivo administration of PAF is
neutropenia. This loss of PMN from the peripheral
circulation could reflect their increased adherence to
vessel walls. Likewise, the aggregated PMN may be
sequestered in capillaries. Craddock and others’9’2#{176}
have suggested that such leukoaggregation contributes
to respiratory distress in disease states where C5a is
present in the circulation. Similarly, in vivo effects
accompanying IgE-mediated anaphylaxis may be
related to PAF activation of PMN.
Although PAF exerts several effects similar to those
elicited by the chemotactic peptide FMLP, it does
show distinct differences. Our CTC studies show that
the membrane structures interacting with PAF are
probably distinct from those for FMLP. Further, PAF
brings about changes in arachidonic acid metabolism
and cell surface charges and promotes aggregation and
adherence without triggering production of reduced
oxygen by products such as superoxide ion. It is
For personal use only. on November 7, 2014.  by guest    www.bloodjournal.org From about aggregation and adherence. Thus, this com-
pound, believed to be of central importance in IgE-
mediated anaphylaxis, is capable of exerting profound
effects of PMN function at concentrations likely to be
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31. Naccache PH, Showell Hi, Becker EL, Sha’afi RI: Transport
of sodium, potassium and calcium across rabbit polymorphonuclear
possible with this compound, therefore, to dissociate
the respiratory burst from other PMN responses.
Relatively low concentrations of PAF elicit PMN
responses. Nanomolar quantities enhance 02 utiliza-
tion, promote CTC fluorescence changes, and bring available in vivo.
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